Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 GeneticVariation group BEFREE In this study we examined the relationship between D/I polymorphism of the ACE gene and diabetic nephropathy in type II diabetic patients who had already developed proliferative retinopathy (n = 45), and were thought to have been in a hyperglycemic state for long enough to develop microangiopathy. 9509566 1998
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 Biomarker group BEFREE These data indicate that ACE gene polymorphism is associated with MI, but not with retinopathy or nephropathy, in patients with NIDDM and suggest that the ACE gene confers susceptibility to diabetic macroangiopathy but not to microangiopathy. 7555560 1995
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.030 Biomarker group BEFREE We investigated the independent change in pulmonary diffusing capacity (DLCO) as one manifestation of pulmonary microangiopathy and to analyze the correlation between DLCO and serum ACE. 10369426 1999
Entrez Id: 11093
Gene Symbol: ADAMTS13
ADAMTS13
0.040 Biomarker group BEFREE Enigmatically, a complete ADAMTS13 deficiency does not lead to continuous microangiopathy. 24449821 2014
Entrez Id: 11093
Gene Symbol: ADAMTS13
ADAMTS13
0.040 Biomarker group BEFREE The congenital or acquired deficiency of the von Willebrand factor (VWF) cleaving protease, ADAMTS-13 has been specifically associated with a diagnosis of thrombotic thrombocytopenic purpura (TTP), a microangiopathy characterized by the formation of occlusive platelet thrombi. 15521921 2004
Entrez Id: 11093
Gene Symbol: ADAMTS13
ADAMTS13
0.040 AlteredExpression group BEFREE We demonstrate a decreased serum level of ADAMTS13 in SSc patients, which may contribute to the vessel microangiopathy observed in systemic sclerosis. 29760619 2018
Entrez Id: 11093
Gene Symbol: ADAMTS13
ADAMTS13
0.040 Biomarker group BEFREE Establishment of an in-house ADAMTS13 (ADAM metallopeptidase with thrombospondin type 1, motif 13) assay in 2013 was used to prevent therapeutic plasma exchange in patients with non-thrombotic thrombocytopenic purpura microangiopathy. 28681548 2017
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.010 AlteredExpression group BEFREE Adiponectin levels are increased in patients with type I diabetes especially in the presence of microangiopathy. 18496510 2008
Entrez Id: 183
Gene Symbol: AGT
AGT
0.020 Biomarker group BEFREE Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology. 12456050 2002
Entrez Id: 183
Gene Symbol: AGT
AGT
0.020 GeneticVariation group BEFREE Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study. 11157174 2001
Entrez Id: 185
Gene Symbol: AGTR1
AGTR1
0.010 GeneticVariation group BEFREE The study aim was to investigate NOS3 VNTR, NOS3 G894T, EDN1 C8002T, ACE I/D, AGT M235T and AGTR1 A1166C in nonobese and obese T2DM patients, and their interaction with the incidence of microangiopathy. 21406182 2011
Entrez Id: 338
Gene Symbol: APOB
APOB
0.010 GeneticVariation group BEFREE Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. 8261646 1993
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 Biomarker group BEFREE Microangiopathy from atherosclerosis or amyloid angiopathy might lead to the formation of these lesions; therefore, there may be associations between CMBs and cardiovascular risk factors, APOE allele status, and brain morphology. 15155954 2004
Entrez Id: 348
Gene Symbol: APOE
APOE
0.020 GeneticVariation group BEFREE Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. 9158631 1997
Entrez Id: 720
Gene Symbol: C4A
C4A
0.020 GeneticVariation group BEFREE The association of the rare C4B3 variant with microangiopathy suggests a genetic component of its aetiology. 3926068 1985
Entrez Id: 720
Gene Symbol: C4A
C4A
0.020 Biomarker group BEFREE The B3 allotype of the fourth component of complement (C4B3) is associated with microangiopathy. 3081112 1986
Entrez Id: 721
Gene Symbol: C4B
C4B
0.020 Biomarker group BEFREE The B3 allotype of the fourth component of complement (C4B3) is associated with microangiopathy. 3081112 1986
Entrez Id: 721
Gene Symbol: C4B
C4B
0.020 GeneticVariation group BEFREE The association of the rare C4B3 variant with microangiopathy suggests a genetic component of its aetiology. 3926068 1985
Entrez Id: 100293534
Gene Symbol: C4B_2
C4B_2
0.020 GeneticVariation group BEFREE The association of the rare C4B3 variant with microangiopathy suggests a genetic component of its aetiology. 3926068 1985
Entrez Id: 100293534
Gene Symbol: C4B_2
C4B_2
0.020 Biomarker group BEFREE The B3 allotype of the fourth component of complement (C4B3) is associated with microangiopathy. 3081112 1986
Entrez Id: 728
Gene Symbol: C5AR1
C5AR1
0.010 Biomarker group BEFREE Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation. 30910380 2019
Entrez Id: 958
Gene Symbol: CD40
CD40
0.010 Biomarker group BEFREE In conclusion, this study revealed the association of microangiopathy, thrombosis and inflammatory infiltrates with nerve degeneration in diabetic nerves, demonstrating that CD40 is a key molecule for the upregulation of HIF-1α and PTEN underlying the severity of microangiopathy. 29549140 2018
Entrez Id: 959
Gene Symbol: CD40LG
CD40LG
0.010 Biomarker group BEFREE Thrombin-induced platelet P-selectin expression was enhanced, and soluble P-selectin and sCD40L concentrations were increased in patients with microangiopathy compared with the control subjects ( p<0.01 for both) and with patients without microangiopathy ( p<0.05 for P-selectin expression and sP-selectin), whereas all three parameters were similar in patients without microangiopathy and in the control subjects. 14963650 2004
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.010 Biomarker group BEFREE Emerging evidence suggests that serum carcinoembryonic antigen (CEA) is elevated in cardiometabolic diseases, which are closely related with microangiopathy. 31398443 2019
Entrez Id: 1071
Gene Symbol: CETP
CETP
0.010 GeneticVariation group BEFREE DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus. 7820935 1994